Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function
Clinical trial NCT05571332 · UNKNOWN
Trial details
- NCT number
- NCT05571332
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2023-12-28
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.